HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jacek S Dubiel Selected Research

Conservative Treatment

1/2010Prognostic significance of new onset atrial fibrillation in acute coronary syndrome patients treated conservatively.
7/2008Spontaneous closure of aorta-to-right atrium fistula after septal occluder implantation.
5/2008Local hospital networks for STEMI treatment for a population of half a million inhabitants increase the use of invasive treatment of acute coronary syndromes to the European recommended level. The Małopolska Registry of Acute Coronary Syndromes 2005-2006.
6/2007More aggressive pharmacological treatment may improve clinical outcome in patients with non-ST-elevation acute coronary syndromes treated conservatively.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jacek S Dubiel Research Topics

Disease

32ST Elevation Myocardial Infarction
11/2014 - 09/2004
17Myocardial Infarction
04/2014 - 01/2002
15Infarction (Infarctions)
01/2014 - 01/2002
13Coronary Artery Disease (Coronary Atherosclerosis)
08/2018 - 03/2003
12Acute Coronary Syndrome
08/2018 - 03/2003
8Cardiovascular Diseases (Cardiovascular Disease)
03/2009 - 09/2002
7Cardiogenic Shock
04/2009 - 11/2005
5Stable Angina
08/2010 - 05/2003
4Hemorrhage
10/2013 - 01/2003
4Atherosclerosis
01/2012 - 01/2004
4Aortic Valve Stenosis (Aortic Stenosis)
11/2011 - 01/2009
4Chest Pain (Chest Pains)
03/2010 - 11/2005
4Heart Diseases (Heart Disease)
12/2009 - 01/2003
4Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy)
08/2009 - 06/2002
4Carotid Artery Diseases
03/2009 - 01/2003
3Ventricular Tachycardia
11/2010 - 01/2008
3Shock
10/2010 - 03/2010
3Myocardial Ischemia (Ischemic Heart Diseases)
01/2010 - 01/2003
3Renal Insufficiency (Renal Failure)
04/2009 - 06/2007
3Unstable Angina
11/2005 - 03/2003
2Type 2 Diabetes Mellitus (MODY)
01/2013 - 01/2007
2Diabetes Mellitus
07/2012 - 04/2009
2Thrombosis (Thrombus)
02/2011 - 01/2005
2Ischemic Stroke
11/2010 - 09/2008
2Stroke (Strokes)
08/2010 - 01/2003
2Chronic Obstructive Pulmonary Disease (COPD)
03/2010 - 04/2009
2Pathologic Constriction (Stenosis)
01/2010 - 01/2003
2Ischemia
01/2010 - 03/2003
2Rheumatoid Arthritis
03/2009 - 03/2007
2Coronary Stenosis (Coronary Artery Stenosis)
01/2005 - 03/2003
2Coronary Disease (Coronary Heart Disease)
09/2004 - 01/2003
1Hypertension (High Blood Pressure)
08/2018
1Insulin Resistance
01/2013
1Essential Thrombocythemia
10/2012
1Takotsubo Cardiomyopathy
10/2012
1Out-of-Hospital Cardiac Arrest
03/2012
1Ventricular Fibrillation
11/2010
1Hyperglycemia
11/2010
1Atrial Fibrillation
11/2010
1Chronic Kidney Failure (Chronic Renal Failure)
08/2010
1Hematoma
08/2010
1Cardiac Sudden Death (Sudden Cardiac Arrest)
08/2009
1Left Ventricular Outflow Obstruction
05/2009
1Non-ST Elevated Myocardial Infarction
02/2009

Drug/Important Bio-Agent (IBA)

13Abciximab (ReoPro)FDA Link
10/2013 - 01/2002
5N,N-dimethylarginine (asymmetric dimethylarginine)IBA
01/2013 - 03/2007
5Tissue Plasminogen Activator (Alteplase)FDA Link
03/2010 - 01/2002
5Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
02/2009 - 09/2004
5omega-Chloroacetophenone (Mace)IBA
12/2006 - 09/2002
4Glucose (Dextrose)FDA LinkGeneric
01/2013 - 01/2007
4Clopidogrel (Plavix)FDA Link
02/2011 - 02/2005
3Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2013 - 03/2007
3Brain Natriuretic Peptide (Natrecor)FDA Link
01/2013 - 01/2010
3C-Reactive ProteinIBA
11/2011 - 09/2004
3Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
01/2011 - 09/2004
3erucylphosphocholineIBA
08/2010 - 07/2008
2Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
04/2014 - 01/2002
2AntibodiesIBA
11/2011 - 03/2009
2Interleukin-6 (Interleukin 6)IBA
11/2011 - 11/2005
2MetalsIBA
02/2011 - 01/2007
2Atorvastatin (Lipitor)FDA Link
01/2011 - 11/2005
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
03/2010 - 02/2005
2Lipoprotein(a)IBA
01/2010 - 01/2009
2GadoliniumIBA
08/2009 - 01/2008
2Heparin (Liquaemin)FDA LinkGeneric
03/2006 - 11/2005
2Platelet Membrane Glycoprotein IIbIBA
05/2003 - 01/2003
1LDL CholesterolIBA
08/2018
1MB Form Creatine KinaseIBA
01/2014
1Indicators and Reagents (Reagents)IBA
01/2013
1Insulin (Novolin)FDA Link
01/2013
1Phentermine (Adipex-P)FDA LinkGeneric
10/2012
1anagrelide (Agrylin)FDA LinkGeneric
10/2012
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2011
1Pharmaceutical PreparationsIBA
02/2011
1pro-brain natriuretic peptide (1-76)IBA
01/2010
1LipidsIBA
01/2010
18-epi-prostaglandin F2alphaIBA
05/2009
1acetyl 4-aminosalicylic acidIBA
03/2009
1Proteins (Proteins, Gene)FDA Link
03/2009
1Nitric Oxide Synthase (NO Synthase)IBA
03/2009
1Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
02/2009
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
02/2009
1Angiotensin IIIBA
02/2009
1Glycoproteins (Glycoprotein)IBA
02/2009
1NitratesIBA
02/2009

Therapy/Procedure

30Percutaneous Coronary Intervention
11/2014 - 01/2002
15Therapeutics
10/2012 - 01/2002
8Stents
11/2014 - 11/2002
5Secondary Prevention
08/2018 - 01/2003
4Length of Stay
11/2010 - 02/2009
4Drug Therapy (Chemotherapy)
03/2010 - 01/2005
4Conservative Treatment
01/2010 - 06/2007
3Catheters
07/2008 - 01/2003
3Thrombolytic Therapy
03/2006 - 01/2003
3Carotid Endarterectomy
06/2005 - 01/2003
2Thrombectomy
10/2012 - 12/2004
1Myocardial Revascularization
08/2018
1Drug-Eluting Stents
02/2011
1Blood Transfusion (Blood Transfusions)
11/2010
1Punctures
08/2010